Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2016

01-10-2016 | Images in Hematology

CLL with intra-cytoplasmic lymphocytic inclusion bodies

Authors: Mohsin Badat, Funmi Oyesanya, Paul Cervi

Published in: International Journal of Hematology | Issue 4/2016

Login to get access

Excerpt

A 72-year-old man was referred due to a raised white cell count of 50.8 × 109/L (lymphocytes 38.8 × 109/L, 76.4 %). White cell immunophenotyping of peripheral blood was performed, with the following results: CD2 2 %; CD3 2 %; CD5 (CD19−) 4 %; Total CD5+ 89 %; CD10 <1 %; CD19 98 %; CD19+ (CD5+) 86 %; CD20 21 % weak; CD23 26 %; CD38 <1 %; CD79a <1 %; CD79b 22 % weak; FMC7 <1 %; CD19+ kappa+ <1 %; and CD19+ lambda+ 94 % weak–moderate. No monoclonal paraprotein was detectable in the blood or urine. Cytogenetic analysis by FISH did not reveal any karyotypic abnormalities. …
Metadata
Title
CLL with intra-cytoplasmic lymphocytic inclusion bodies
Authors
Mohsin Badat
Funmi Oyesanya
Paul Cervi
Publication date
01-10-2016
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2016
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2067-2

Other articles of this Issue 4/2016

International Journal of Hematology 4/2016 Go to the issue

Original Article

Serum ferritin is an independent factor in coronary artery stenosis among hemodialysis patients

Case Report

Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus

Case Report

Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy

Case Report

Pleuroparenchymal fibroelastosis after allogenic hematopoietic stem cell transplantation: important histological component of late-onset noninfectious pulmonary complication accompanied with recurrent pneumothorax

Case Report

Pathological findings in a case of bone marrow carcinosis due to gastric cancer complicated by disseminated intravascular coagulation and thrombotic microangiopathy

Original Article

Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits